E. Takakuwa

Tissue factor in plasma of patients with disseminated intravascular coagulation

A. Shibata, H. Takahashi, Hoyu Takahashi, 1994, American journal of hematology.

Evaluation of oral anticoagulant therapy by measuring plasma prothrombin fragment 1 + 2

A. Shibata, H. Takahashi, N. Satoh, 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Plasma von Willebrand factor proteolysis in patients with chronic myeloproliferative disorders: no possibility of ex vivo degradation by calcium-dependent proteases.

A. Shibata, H. Takahashi, W. Tatewaki, 1989, Thrombosis research.

Evaluation of Clinical Usefulness of a Rapid Measurement of Plasmin-α2-Plasmin Inhibitor Complex by Latex Agglutination Immunoassay

A. Shibata, Hoyu Takahashi, K. Wada, 1993 .

Early Erythroblastic Leukemia Presenting as De Novo Acute Leukemia.

A Shibata, T Koike, E Takakuwa, 1990, Leukemia & lymphoma.

Analysis of Fibrinolytic States by Differential Quantification of Fibrinogen Degradation Products and Fibrin Degradation Products

H. Niwano, A. Shibata, Hoyu Takahashi, 1990 .

Protein C Levels in Disseminated Intravascular Coagulation and Thrombotic Thrombocytopenic Purpura: Its Correlation with Other Coagulation Parameters

Hoyu Takahashi, M. Hanano, A. Shibata, 1985, Thrombosis and Haemostasis.

Activation of Blood Coagulation and Fibrinolysis in Selected Disease States Assessed by Plasma Levels of Thrombin-Antithrombin III Complex and Plasmin-α2-Plasmin Inhibitor Complex

H. Niwano, A. Shibata, Hoyu Takahashi, 1990 .

Protein C and vitamin K-dependent coagulation factors in patients on long-term warfarin therapy

A. Shibata, Hoyu Takahashi, S. Hayashi, 1986 .

Plasma levels of protein C and vitamin K-dependent coagulation factors in patients on long-term oral anticoagulant therapy.

S. Hayashi, A. Shibata, H. Takahashi, 1986, The Tohoku journal of experimental medicine.